SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Myriad Genetics, Inc. (MYGN)
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
2355 65 0 MYGN
Emcee:  s myers Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1680<i>from the "don't hold your breath" and "zeta likes thscaram(o)uche-10/16/2005
1679again, from the "don't hold your breath" and "zeta likes thisscaram(o)uche-10/14/2005
1678Thanks Rick...EOMsim1-10/14/2005
1677just noticed...... the pipe page has also been updated to include tutorials onscaram(o)uche-10/13/2005
1676updated......... myriad.comscaram(o)uche-10/13/2005
1675>> Couldn't happen to a nicer bunch of guys! << :-) :-)scaram(o)uche-10/12/2005
1674Couldn't happen to a nicer bunch of guys! LOL But I guess they made out liRobohogs-10/12/2005
1673Message 21785556scaram(o)uche-10/12/2005
1672only guessing...... wild guesses..... 1203 was a biological, and biologicascaram(o)uche-10/12/2005
1671Does anyone have any idea if there's a relationship (if any) between MPC-092sim1-10/12/2005
1670oral thrombin inhibitor..... holy grail, not the first in development however.scaram(o)uche-10/11/2005
1669<i>rapidly nearing completion</i> I hope they let shareholders knowkeokalani'nui-10/11/2005
1668Myriad Genetics Advances Antithrombin Drug Development - MPC-0920 scaram(o)uche-10/11/2005
1667Could this be it? Message 21652168sim1-10/9/2005
1666Rick, Somewhere here on SI is another post indicated that India has the lowest Harold Engstrom-10/9/2005
1665United States Patent Application 20050222143 Kind Code A1 Huber, Vincent ; sim1-10/9/2005
1664United States Patent Application 20050222029 Kind Code A1 Bartel, Paul ; etsim1-10/9/2005
16631. they haven't mentioned 4505 much of late; 2. they never mentioned anytscaram(o)uche-10/6/2005
1662>>no significant difference between TKA731 and placebo in change in pain rtuck-10/6/2005
1661shux..about TKA731 failure.. Has anybody noticed there isn't much going on zeta1961-10/5/2005
1660Eur J Pain. 2005 Sep 28; [Epub ahead of print] The NK(1)-receptor antagonist Tscaram(o)uche-10/5/2005
165910-03-2005 Prolexys Pharmaceuticals, Inc. Licenses the Prolexys’ Human Interactoscaram(o)uche-10/3/2005
1658<i>It is a good thing to understand that, when assays can't be establiDewDiligence_on_SI-9/30/2005
1657If I screen a hybridization plate against 100 antigens, does it mean that a posiscaram(o)uche-9/30/2005
1656If you look at enough things, something is bound to appear statistically signifiDewDiligence_on_SI-9/30/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News